The Rise of Specialty Drugs and the Impact on Market Growth

Specialty drugs — often described as “prescription drugs that are difficult to manufacture and require special handling or administration, have limited distribution, target a narrow group of chronic diseases, are costly, and require ongoing clinical support — will drive nearly all of the pharmaceutical industry’s market growth from 2015–2020. Drug Channels projects the total pharmaceutical…

2017 Pipeline Report: Trends & Projections in Biopharma

Complexity is the operative word in Pharm Exec’s 2017 Pipeline Report. Complex diseases are driving the development of new and innovative therapies while the market adjusts to manufacturing challenges and increasing drug costs. We’ve recapped some of the main topics in the report, including CAR-T therapies, combination treatments and nonalcoholic steatohepatitis (NASH), among others.  …